Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. - Wikidata - awgldk - TriplyDB

Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.

Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.

http://www.wikidata.org/entity/Q37328406

about

Anti-Inflammatory Applications of Melittin, a Major Component of Bee Venom: Detailed Mechanism of Action and Adverse Effects Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles.The structure, molecular dynamics, and energetics of centrin-melittin complex Selective ruthenium labeling of the tryptophan residue in the bee venom Peptide melittin Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9 Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation Hp1404, a new antimicrobial peptide from the scorpion Heterometrus petersii Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery Modern trends in animal venom research - omics and nanomaterials Recent Advances in (19)Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions.Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy Perfluorocarbon nanoparticles: evolution of a multimodality and multifunctional imaging agent.Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.Simulation of fusion-mediated nanoemulsion interactions with model lipid bilayers.Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions Phase-shift, stimuli-responsive drug carriers for targeted delivery.Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function Recent advances in developing insect natural products as potential modern day medicines Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions.Targeted Nanodelivery of Drugs and Diagnostics Identification of a novel lytic peptide for the treatment of solid tumours.Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures.Characterization of perfluorooctylbromide-based nanoemulsion particles using atomistic molecular dynamics simulations Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma.Gain-of-function analogues of the pore-forming peptide melittin selected by orthogonal high-throughput screening.RNA interference knockdown of DNA methyl-transferase 3 affects gene alternative splicing in the honey bee Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling Synthetic molecular evolution of pore-forming peptides by iterative combinatorial library screening.Melittin-glutathione S-transferase fusion protein exhibits anti-inflammatory properties and minimal toxicity.alphaVbeta3-targeted copper nanoparticles incorporating an Sn 2 lipase-labile fumagillin prodrug for photoacoustic neovascular imaging and treatment.Targeted nanogels: a versatile platform for drug delivery to tumors Learning from host-defense peptides: cationic, amphipathic peptoids with potent anticancer activity.Nanoparticle incorporation of melittin reduces sperm and vaginal epithelium cytotoxicity.Nanoparticle delivery of a peptide targeting EGFR signaling Interaction of melittin peptides with perfluorocarbon nanoemulsion particles.Conformational Fine-Tuning of Pore-Forming Peptide Potency and Selectivity.A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittin

P2860

Q26749090-E461C893-E8F9-4235-8A19-AC581117CA66 Q27027613-C6E51741-149A-4A30-8E5B-1E2EEE216D91 Q27301457-6D5FEFBE-6440-4EDB-9A45-685B79CDDCEC Q27674964-3E9C086B-B365-474E-87D2-00D4B2FF21F2 Q27698009-8954A47B-8253-419F-93FF-FB9D78F1178D Q28389837-16FE0B25-EF1C-4238-B994-2E658042FCFA Q28394194-5F126F7F-A480-46B4-A449-48869907CE1B Q28538819-EAB502D1-8F38-4A67-A7FD-B9889AEBC85C Q28834598-6996A15B-022F-40ED-BD53-146878F22A3A Q29248950-135CBCD2-4531-49B3-A388-0C0814652660 Q30385272-2DC72DA9-5449-4F4A-9841-1171E5406AAF Q30426880-A10C96C7-D2EC-4370-99D3-70DE70B57BE1 Q30434964-586C6E94-56BE-4209-ABBA-09F8B3FBD32A Q30436623-F16979DE-98AF-4B8D-B82E-497A6C484416 Q30450131-9A2153E6-57DA-47CB-B43B-D69F22755471 Q30459662-CEB03326-E7D1-4431-9741-677ADB4B05DF Q30465710-F15AF7E7-D9BC-41B0-B2EA-B292480E8F99 Q30466278-CCAC4B7A-6F68-49EB-ABB2-27BC257ED668 Q30474759-50C86D50-AF4F-4C4E-940C-220F0B6DE303 Q30576097-A2F33EA5-2263-4B56-BEC3-D31F52EF9F1D Q33634334-3C8E1153-C746-4A6A-9513-8A37CC3CD4DE Q33684461-104790BC-B0B7-4876-87E5-F6B7AB091C0C Q33900258-3E9BF368-2C1F-4F22-B68F-4E57A72E88EE Q33925341-AFF2A56F-E1FF-4484-BCF1-C7BB7CF5AE63 Q34017152-2092DB26-B295-4BD3-9323-4279C104D0F6 Q34051542-4022C40D-0750-44DA-9F48-DD62740A423F Q34094167-13BAC1BA-1777-47B5-BDDE-B277586EDE56 Q34316505-252528E9-EE27-42E2-B208-9A3B1D637CB3 Q34357477-7F8A161F-E430-48AD-9228-79CE96B6C139 Q34381627-89A77796-6A81-4DC0-94F3-93F5EDDBBFBA Q34581262-59F0FCC2-9E85-4B8C-90FD-D722B63E4892 Q34620675-D6F6EAB8-5BAA-4DF3-BCCA-B359D65A85A4 Q34785222-6963C0DC-4379-4383-8C13-C8F02D9648FC Q35038164-72024BC2-0115-44B0-AC34-C215F0DC9611 Q35109017-EFC1A373-555A-4CC4-8988-2750163E86DB Q35153213-A1BEBEB0-B18F-4CD2-B6AC-54FBDA673454 Q35589627-BB93BC15-43A8-4209-96C7-25BE0A74EAA9 Q35631698-F6CE872D-0607-4252-8C7F-369141B31CEF Q35859779-AF1ED5EB-8E90-49E4-92E2-DD4AE2D16556 Q35967737-FA703601-47E8-4273-8B29-63DAF5A340B5

P2860

Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.

http://www.wikidata.org/entity/Q37328406

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Molecularly targeted nanocarri ...... n mice, reducing tumor growth.

@en

Molecularly targeted nanocarri ...... n mice, reducing tumor growth.

@nl

type

label

Molecularly targeted nanocarri ...... n mice, reducing tumor growth.

@en

Molecularly targeted nanocarri ...... n mice, reducing tumor growth.

@nl

prefLabel

Molecularly targeted nanocarri ...... n mice, reducing tumor growth.

@en

Molecularly targeted nanocarri ...... n mice, reducing tumor growth.

@nl

P1433

Q37328406-2666EDEA-E9C9-477B-80CA-E82641F5D605

P1476

Q37328406-15832B9B-76D0-4E14-AE52-963D270A909C

P2093

Q37328406-00F32FD9-03D0-47D4-8A5A-C1D17EBEC5E6

Q37328406-0C686FB4-18B8-4922-84C6-D0C2C19BA7A9

Q37328406-22902606-93DB-4F23-834B-FEB8CA8E0996

Q37328406-47344267-A79C-4DD9-BBBF-F5087F64FBB5

Q37328406-64D7AB49-B0C4-41F4-8C34-9CB0FD985215

Q37328406-C99450BE-531A-4DC1-922D-8D9E9E33D48F

Q37328406-D4A6E542-7294-405E-B051-B9C73CCCA534

Q37328406-DDF1DF31-4A14-49E1-872A-A50921EA5185

Q37328406-F735E67C-EB97-4EF0-96DC-726257A9EA99

P2860

Q37328406-0234E3D6-0B2A-4603-9617-DDB86044D0B9

Q37328406-0FC3C919-B63F-429B-B35B-7C319E06F0CF

Q37328406-13289294-5E8C-4950-85BD-DC86A74CD03D

Q37328406-146939D5-C04C-4B78-A419-3D2BB7C978FE

Q37328406-19861C8A-5A59-45EA-8DF9-1D4B2BC3DD96

Q37328406-1A300328-E5BF-49E7-9107-19E67BD69861

Q37328406-27088BFC-15BC-4024-8127-C4926B99DE70

Q37328406-2CDCE809-E301-43D6-9D69-36F939371252

Q37328406-2CF701AC-6A3C-4916-8FA3-FD0029334CB3

Q37328406-31ADEE84-C814-41D7-832C-58A7C9953869

P304

Q37328406-AD12A699-91F8-46B8-BB13-6F1A3CE23958

P31

Q37328406-479DCDB2-CF32-4F25-84BE-F51235B0C293

P356

Q37328406-B3C241F1-53D4-499F-82F7-78993769F93E

P407

Q37328406-11C656AC-365C-4D09-845A-A8DEF092DEBF

P433

Q37328406-FE4B8292-9CCE-4094-BFB4-26EFCA7FB260

P478

Q37328406-E73B6A81-8AB1-4A4A-ADF7-B09A4E4DFB67

P577

Q37328406-9676AC40-5D25-419C-B5D4-D2A2F77F36AF

P5875

Q37328406-052D4C0E-1D76-4157-9138-A785D2C6F043

P698

Q37328406-05CDA417-F262-4FF4-AEF4-F2E6B1768F2B

P921

Q37328406-2008F7D4-3B1F-4CC8-8A97-EFAB59FD5AFB

P932

Q37328406-79785218-DB49-48DA-BC50-4B0F472C2CEA

P356

P1433

Journal of Clinical Investigation

P1476

Molecularly targeted nanocarri ...... n mice, reducing tumor growth.

@en

P2093

Grace Hu

http://www.w3.org/2001/XMLSchema#string

Gregory M Lanza

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Arbeit

http://www.w3.org/2001/XMLSchema#string

John E Heuser

http://www.w3.org/2001/XMLSchema#string

Jon N Marsh

http://www.w3.org/2001/XMLSchema#string

Neelesh R Soman

http://www.w3.org/2001/XMLSchema#string

Paul H Schlesinger

http://www.w3.org/2001/XMLSchema#string

Samuel A Wickline

http://www.w3.org/2001/XMLSchema#string

Steven L Baldwin

http://www.w3.org/2001/XMLSchema#string

P2860

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents

Studies on anticancer activities of antimicrobial peptides

Barrel-stave model or toroidal model? A case study on melittin pores.

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

Requirement of vascular integrin alpha v beta 3 for angiogenesis

Proteomic analysis of tumor establishment and growth in the B16-F10 mouse melanoma model.

Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma.

Perfluoro compounds as blood substitutes.

Mass envenomations by honey bees and wasps

P304

2830-2842

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI38842

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26786189

http://www.w3.org/2001/XMLSchema#string

P698

19726870

http://www.w3.org/2001/XMLSchema#string

P921

P932

2735896

http://www.w3.org/2001/XMLSchema#string